175 related articles for article (PubMed ID: 25104409)
1. Quantum dots targeted to vascular endothelial growth factor receptor 2 as a contrast agent for the detection of colorectal cancer.
Carbary-Ganz JL; Barton JK; Utzinger U
J Biomed Opt; 2014 Aug; 19(8):086003. PubMed ID: 25104409
[TBL] [Abstract][Full Text] [Related]
2. In vivo molecular imaging of colorectal cancer using quantum dots targeted to vascular endothelial growth factor receptor 2 and optical coherence tomography/laser-induced fluorescence dual-modality imaging.
Carbary-Ganz JL; Welge WA; Barton JK; Utzinger U
J Biomed Opt; 2015; 20(9):096015. PubMed ID: 26397238
[TBL] [Abstract][Full Text] [Related]
3. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
4. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
[TBL] [Abstract][Full Text] [Related]
5. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment.
Zdobnova TA; Dorofeev SG; Tananaev PN; Vasiliev RB; Balandin TG; Edelweiss EF; Stremovskiy OA; Balalaeva IV; Turchin IV; Lebedenko EN; Zlomanov VP; Deyev SM
J Biomed Opt; 2009; 14(2):021004. PubMed ID: 19405717
[TBL] [Abstract][Full Text] [Related]
8. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.
Shin SJ; Hwang JW; Ahn JB; Rha SY; Roh JK; Chung HC
Invest New Drugs; 2013 Feb; 31(1):1-13. PubMed ID: 22539090
[TBL] [Abstract][Full Text] [Related]
9. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
10. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
[TBL] [Abstract][Full Text] [Related]
11. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted quantum dots can help surgeons find tumor boundaries.
Arndt-Jovin DJ; Kantelhardt SR; Caarls W; de Vries AH; Giese A; Jovin Ast TM
IEEE Trans Nanobioscience; 2009 Mar; 8(1):65-71. PubMed ID: 19304503
[TBL] [Abstract][Full Text] [Related]
13. Cell tracking and detection of molecular expression in live cells using lipid-enclosed CdSe quantum dots as contrast agents for epi-third harmonic generation microscopy.
Chang CF; Chen CY; Chang FH; Tai SP; Chen CY; Yu CH; Tseng YB; Tsai TH; Liu IS; Su WF; Sun CK
Opt Express; 2008 Jun; 16(13):9534-48. PubMed ID: 18575520
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
[TBL] [Abstract][Full Text] [Related]
15. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of brain cancer using epidermal growth factor single domain antibody bioconjugated to near-infrared quantum dots.
Fatehi D; Baral TN; Abulrob A
J Nanosci Nanotechnol; 2014 Jul; 14(7):5355-62. PubMed ID: 24758031
[TBL] [Abstract][Full Text] [Related]
17. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
[TBL] [Abstract][Full Text] [Related]
18. Labeling of mesenchymal stem cells by bioconjugated quantum dots.
Shah BS; Clark PA; Moioli EK; Stroscio MA; Mao JJ
Nano Lett; 2007 Oct; 7(10):3071-9. PubMed ID: 17887799
[TBL] [Abstract][Full Text] [Related]
19. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
